NorthWest Biotherapeutics Inc (NWBO)

[Johnni]

DC-Vax still beat out the highest reported OS for recent MGMT-methylated patients. The OS from time of surgery is 33.0 months with DC-Vax.

From the JAMA Oncology paper by Liau et al.:

“In patients with nGBM with methylated MGMT, mOS was 30.2 (95% CI, 23.7-33.9) months from randomization (33.0 months from surgery) in 90 patients receiving DCVax-L vs 21.3 (95% CI, 18.3-25.1) months in the 199 patients in the ECP (HR, 0.74; 95% CI, 0.55-1.00, P = .03).”